In the present study, we identified 5 FR-DELs (DOCK8-AS1, SNHG17, RUSC1-AS1, LINC02609, and LUCAT1) that could be used as biomarkers to predict the outcome of renal cancer. Here, DOCK8 is linked to renal carcinoma.